116 related articles for article (PubMed ID: 10732763)
1. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway.
Ueoka Y; Kato K; Kuriaki Y; Horiuchi S; Terao Y; Nishida J; Ueno H; Wake N
Br J Cancer; 2000 Feb; 82(4):891-9. PubMed ID: 10732763
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway.
Ueoka Y; Kato K; Wake N
Mol Cell Endocrinol; 2003 Apr; 202(1-2):81-8. PubMed ID: 12770735
[TBL] [Abstract][Full Text] [Related]
3. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.
Gaggioli C; Deckert M; Robert G; Abbe P; Batoz M; Ehrengruber MU; Ortonne JP; Ballotti R; Tartare-Deckert S
Oncogene; 2005 Feb; 24(8):1423-33. PubMed ID: 15608673
[TBL] [Abstract][Full Text] [Related]
4. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
Kim MS; Lee EJ; Kim HR; Moon A
Cancer Res; 2003 Sep; 63(17):5454-61. PubMed ID: 14500381
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
6. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
[TBL] [Abstract][Full Text] [Related]
7. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
Recio JA; Merlino G
Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
[TBL] [Abstract][Full Text] [Related]
9. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.
Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H
Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
Matsushita A; Götze T; Korc M
Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of epidermal growth factor and hepatocyte growth factor on human ovarian cancer cell invasion and migration: role of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.
Zhou HY; Pon YL; Wong AS
Endocrinology; 2007 Nov; 148(11):5195-208. PubMed ID: 17673518
[TBL] [Abstract][Full Text] [Related]
13. Requirement of regulated activation of Ras for response of MDCK cells to hepatocyte growth factor/scatter factor.
Terauchi R; Kitamura N
Exp Cell Res; 2000 May; 256(2):411-22. PubMed ID: 10772814
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells.
Wong AS; Leung PC; Auersperg N
Gynecol Oncol; 2000 Aug; 78(2):158-65. PubMed ID: 10926796
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
16. MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.
Higuchi T; Orita T; Katsuya K; Yamasaki Y; Akiyama K; Li H; Yamamoto T; Saito Y; Nakamura M
Mol Cell Biol; 2004 Sep; 24(17):7456-68. PubMed ID: 15314156
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
Recio JA; Merlino G
Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells.
Lim YC; Park HY; Hwang HS; Kang SU; Pyun JH; Lee MH; Choi EC; Kim CH
Cancer Lett; 2008 Nov; 271(1):140-52. PubMed ID: 18632202
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis.
Fassetta M; D'Alessandro L; Coltella N; Di Renzo MF; Rasola A
Cell Signal; 2006 Nov; 18(11):1967-76. PubMed ID: 16677802
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
